Conecte-se

Bibliografias temáticas / Cystinuria / Artigos de revistas

Siga este link para ver outros tipos de publicações sobre o tema: Cystinuria.

Artigos de revistas sobre o tema "Cystinuria"

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 24 de janeiro de 2023

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Cystinuria".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

Kovaříková, Simona, Petr Maršálek e Kateřina Vrbová. "Cystinuria in Dogs and Cats: What Do We Know after Almost 200 Years?" Animals 11, n.º 8 (19 de agosto de 2021): 2437. http://dx.doi.org/10.3390/ani11082437.

Texto completo da fonte

Resumo:

The purpose of this review is to summarize current knowledge on canine and feline cystinuria from available scientific reports. Cystinuria is an inherited metabolic defect characterized by abnormal intestinal and renal amino acid transport in which cystine and the dibasic amino acids ornithine, lysine, and arginine are involved (COLA). At a normal urine pH, ornithine, lysine, and arginine are soluble, but cysteine forms a dimer, cystine, which is relatively insoluble, resulting in crystal precipitation. Mutations in genes coding COLA transporter and the mode of inheritance were identified only in some canine breeds. Cystinuric dogs may form uroliths (mostly in lower urinary tract) which are associated with typical clinical symptoms. The prevalence of cystine urolithiasis is much higher in European countries (up to 14% according to the recent reports) when compared to North America (United States and Canada) where it is approximately 1–3%. Cystinuria may be diagnosed by the detection of cystine urolithiasis, cystine crystalluria, assessment of amino aciduria, or using genetic tests. The management of cystinuria is aimed at urolith removal or dissolution which may be reached by dietary changes or medical treatment. In dogs with androgen-dependent cystinuria, castration will help. In cats, cystinuria occurs less frequently in comparison with dogs.

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Font-Llitjós, Mariona, Lídia Feliubadaló, Meritxell Espino, Ramon Clèries, Sandra Mañas, Isabelle M. Frey, Sara Puertas et al. "Slc7a9knockout mouse is a good cystinuria model for antilithiasic pharmacological studies". American Journal of Physiology-Renal Physiology 293, n.º 3 (setembro de 2007): F732—F740. http://dx.doi.org/10.1152/ajprenal.00121.2007.

Texto completo da fonte

Resumo:

Cystinuria is a hereditary disorder caused by a defect in the apical membrane transport system for cystine and dibasic amino acids in renal proximal tubules and intestine, resulting in recurrent urolithiasis. Mutations in SLC3A1 and SLC7A9 genes, that codify for rBAT/b0,+AT transporter subunits, cause type A and B cystinuria, respectively. In humans, cystinuria treatment is based on the prevention of calculi formation and its dissolution or breakage. Persistent calculi are treated with thiols [i.e., d-penicillamine (DP) and mercaptopropionylglycine (MPG)] for cystine solubilization. We have developed a new protocol with DP to validate our Slc7a9 knockout mouse model for the study of the therapeutic effect of drugs in the treatment of cystine lithiasis. We performed a 5-wk treatment of individually caged lithiasic mutant mice with a previously tested DP dose. To appraise the evolution of lithiasis throughout the treatment a noninvasive indirect method of calculi quantification was developed: calculi mass was quantified by densitometry of X-ray images from cystinuric mice before and after treatment. Urine was collected in metabolic cage experiments to quantify amino acids in DP-treated and nontreated, nonlithiasic mutant mice. We found significant differences between DP-treated and nontreated knockout mice in calculi size and in urinary cystine excretion. Histopathological analysis showed that globally nontreated mutant mice had more severe and diffuse urinary system damage than DP-treated mice. Our results validate the use of this mouse model for testing the efficacy of potential new drugs against cystinuria.

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Döven, Serra Sürmeli, Ali Delibaş, Hakan Taşkınlar e Ali Naycı. "The impact of surgical intervention on renal function in cystinuria". Brazilian Journal of Nephrology 40, n.º 3 (21 de junho de 2018): 256–60. http://dx.doi.org/10.1590/2175-8239-jbn-2018-0034.

Texto completo da fonte

Resumo:

ABSTRACT Introduction: Cystinuria is an autosomal recessive disorder due to intestinal and renal transport defects in cystine and dibasic amino acids, which result in recurrent urolithiasis and surgical interventions. This study aimed to assess the impact of surgical interventions on renal function by analyzing estimated glomerular filtration rates. Methods: Thirteen pediatric patients with cystinuria, who were followed-up in a single tertiary institution between 2004 and 2016, were included in the study. Medical records were reviewed to collect data on clinical presentation of patients, urine parameters, stone formation, medical treatment, surgical intervention, stone recurrence after surgical procedure, stone analysis, ultrasonography, 99m-technetium dimercaptosuccinic acid (99mTc-DMSA) radionuclide imaging results, and follow-up time. Creatinine clearances estimated by modified Schwartz (eGFR) formula before and after surgery were used to assess renal function and compared statistically. Results: Nine patients (69.2%) had renal scarring which were detected with 99mTc-DMSA radionuclide imaging. In ten patients (76.9%), open surgical intervention for stones were needed during follow-up. Significant difference was not detected between eGFR before and after surgical intervention (mean 92 versus 106, p = 0.36). Nine of the patients (69.2%) were stone free in the last ultrasonographic examination. Relapses of stone after surgery were seen in 66.6% of patients who underwent surgical intervention. Conclusions: Surgical interventions for urinary stones are commonly required in patients with cystinuria. Renal scarring is a prevalent finding in cystinuric patients. Surgical interventions have no negative impact on eGFR in patients with cystinuria according to the present study.

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Feld, Ronald D., e Zakariya K. Shihabi. "Cystinuria". CRC Critical Reviews in Clinical Laboratory Sciences 26, n.º 3 (janeiro de 1988): 243–61. http://dx.doi.org/10.3109/10408368809105891.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Strologo, Luca Dello, e Gianfranco Rizzoni. "Cystinuria". Acta Paediatrica 95 (1 de julho de 2006): 31–33. http://dx.doi.org/10.1080/08035320600649473.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Strologo, Luca Dello, e Gianfranco Rizzoni. "Cystinuria". Acta Paediatrica 95 (2 de janeiro de 2007): 31–33. http://dx.doi.org/10.1111/j.1651-2227.2006.tb02412.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Milliner, D. S. "Cystinuria". Endocrinology and Metabolism Clinics of North America 19, n.º 4 (dezembro de 1990): 889–907. http://dx.doi.org/10.1016/s0889-8529(18)30299-8.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Mattoo, Aditya, e David S. Goldfarb. "Cystinuria". Seminars in Nephrology 28, n.º 2 (março de 2008): 181–91. http://dx.doi.org/10.1016/j.semnephrol.2008.01.011.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Scrivner, C. R. "Cystinuria". Journal of Urology 137, n.º 5 (maio de 1987): 1069–70. http://dx.doi.org/10.1016/s0022-5347(17)44383-7.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Scriver, Charles R. "Cystinuria". New England Journal of Medicine 315, n.º 18 (30 de outubro de 1986): 1155–57. http://dx.doi.org/10.1056/nejm198610303151808.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Dahlem, Peter. "Cystinuria". Journal of Pediatric Biochemistry 04, n.º 02 (3 de agosto de 2016): 093–99. http://dx.doi.org/10.1055/s-0036-1586467.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

McNamara, Pamela D., Claire T. Rea, Kenneth C. Bovee, Robert A. Reynolds e Stanton Segal. "Cystinuria in dogs: Comparison of the cystinuric component of the Fanconi syndrome in Basenji dogs to isolated cystinuria". Metabolism 38, n.º 1 (janeiro de 1989): 8–15. http://dx.doi.org/10.1016/0026-0495(89)90173-x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Miyamoto, K., K. Katai, S. Tatsumi, K. Sone, H. Segawa, H. Yamamoto, Y. Taketani et al. "Mutations of the basic amino acid transporter gene associated with cystinuria". Biochemical Journal 310, n.º 3 (15 de setembro de 1995): 951–55. http://dx.doi.org/10.1042/bj3100951.

Texto completo da fonte

Resumo:

To investigate the function of a basic and neutral amino acid transporter-like protein (rBAT) which is a candidate gene for cystinuria, we analysed the rBAT gene in cystinuric patients. Patient 1 is a compound heterozygote with mutations in the rBAT gene causing a glutamine-to-lysine transition at amino acid 268, and a threonine-to-alanine transition at amino acid 341, who inherited these alleles from his mother (E268K) and father (T341A), respectively. Injection of T341A and E268K mutant cRNAs into oocytes decreased transport activity to 53.9% and 62.5% of control (L-cystine transport activity in oocytes injected with wild-type rBAT cRNA), respectively. Co-injection of E268K and T341A into oocytes strongly decreased amino acid transport activity to 28% of control. On the other hand, co-injection of wild-type and mutant rBAT did not decrease transport activity. Furthermore, immunological studies have demonstrated that the reduction of amino acid transport is not due to a decrease in the amount of rBAT protein expressed in oocyte membranes. These results indicate that mutations in the rBAT gene are crucial disease-causing lesions in cystinuria. In addition, co-injection experiments suggest that rBAT may function as a transport activator or regulatory subunit by homo- or hetero-multimer complex formation.

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

STOLLER, MARSHALL L., MICHAEL W. McDONALD, DONALD L. GENTLE, JEREMY BRUCE e ROGER K. LOW. "Acalculous Cystinuria". Journal of Endourology 11, n.º 4 (agosto de 1997): 233–38. http://dx.doi.org/10.1089/end.1997.11.233.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

López de Heredia, Miguel, Lourdes Muñoz, Ciriaco Carru, Salvatore Sotgia, Angelo Zinellu, Carmen Serra, Amadeu Llebaria, Yukio Kato e Virginia Nunes. "S-Methyl-L-Ergothioneine to L-Ergothioneine Ratio in Urine Is a Marker of Cystine Lithiasis in a Cystinuria Mouse Model". Antioxidants 10, n.º 9 (7 de setembro de 2021): 1424. http://dx.doi.org/10.3390/antiox10091424.

Texto completo da fonte

Resumo:

Cystinuria, a rare inherited aminoaciduria condition, is characterized by the hyperexcretion of cystine, ornithine, lysine, and arginine. Its main clinical manifestation is cystine stone formation in the urinary tract, being responsible for 1–2% total and 6–8% pediatric lithiasis. Cystinuria patients suffer from recurrent lithiasic episodes that might end in surgical interventions, progressive renal functional deterioration, and kidney loss. Cystinuria is monitored for the presence of urinary cystine stones by crystalluria, imaging techniques or urinary cystine capacity; all with limited predicting capabilities. We analyzed blood and urine levels of the natural antioxidant L-ergothioneine in a Type B cystinuria mouse model, and urine levels of its metabolic product S-methyl-L-ergothioneine, in both male and female mice at two different ages and with different lithiasic phenotype. Urinary levels of S-methyl-L-ergothioneine showed differences related to age, gender and lithiasic phenotype. Once normalized by L-ergothioneine to account for interindividual differences, the S-methyl-L-ergothioneine to L-ergothioneine urinary ratio discriminated between cystine lithiasic phenotypes. Urine S-methyl-L-ergothioneine to L-ergothioneine ratio could be easily determined in urine and, as being capable of discriminating between cystine lithiasis phenotypes, it could be used as a lithiasis biomarker in cystinuria patient management.

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Byrd, DennIs J., Marion Lind e Johannes Brodehl. "Diagnostic and genetic studies in 43 patients with classic cystinuria". Clinical Chemistry 37, n.º 1 (1 de janeiro de 1991): 68–73. http://dx.doi.org/10.1093/clinchem/37.1.68.

Texto completo da fonte

Resumo:

Abstract We present results for laboratory screening and diagnostic tests--cyanide-nitroprusside test, semi-quantitative thin-layer chromatography, and quantitative amino acid column chromatography--of 43 patients with classic cystinuria. We report the efficaciousness of the cyanide-nitroprusside test and of thin-layer chromatography, as compared with quantitative amino acid chromatography, for detecting heterozygotes for type II or III cystinuria. The quantitative results for aminoaciduria in 57 blood relatives in 23 families were used to categorize the index patients with classic cystinuria. By column chromatography the ranges of excretion rates (mumol/24 h per 1.73 m2 body surface area) of diagnostic amino acids in the index patients were as follows: cystine 556-54044 (normal 20-128), arginine 131-11543 (10-80), lysine 768-21848 (51-514), ornithine 185-5685 (0-80). Also by column chromatography the median values for arginine and ornithine excretion in cystine-lysinuric heterozygotes (among the 57 blood relatives) were significantly higher (P less than 0.01) than in controls but never approached the values for homozygotes. The cyanide-nitroprusside test results were positive in urine samples of 41 of 43 index patients and in 16 (51.6%) of the urine samples of 31 obligate heterozygotes with column chromatographically proven cystine-lysinuria. Thin-layer chromatography detected all of the homozygotes, all the compound heterozygotes, and 54.8% of the carriers. According to the type of aminoaciduria in their relatives, 11 patients with classic cystinuria could be classified as having classic cystinuria type I, 11 as having type II or III, and three as being compound heterozygotes. We discuss the implications of these results for correct diagnoses and for genetic studies in classic cystinuria.

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Bazin, Dominique, Michel Daudon, Gilles André, Raphael Weil, Emmanuel Véron e Guy Matzen. "Therapy modifies cystine kidney stones at the macroscopic scale. Do such alterations exist at the mesoscopic and nanometre scale?" Journal of Applied Crystallography 47, n.º 2 (28 de março de 2014): 719–25. http://dx.doi.org/10.1107/s1600576714004658.

Texto completo da fonte

Resumo:

With an incidence of 1:7000 births, cystinuria, the most frequent cause of stone formation among genetic diseases, represents a major medical problem. Twenty-five cystine stones randomly selected from cystinuric patients were investigated. From a crystallographic point of view, cystine stones are composed of micrometre size crystallites, which are made up of an aggregation of nanocrystals. Through scanning electron microscopy, the morphology and size of the crystallites have been described, while the size of the nanocrystals was investigated by means of powder neutron diffraction. Powder neutron diffraction analysis and/or scanning electron microscopy examination of cystine stones provide evidence that usual alkalinization by sodium bicarbonate associated with high diuresis significantly reduces the size of both nanocrystals and crystallites, while for other treatments, including alkalinizing drugs and thiol derivatives, the data suggest mainly changes in the topology of crystallites. Alkalinization with sodium bicarbonate affects cystine kidney stones at the mesoscopic and nanoscopic scales, while other medical treatments only alter their surface. Such an approach may help to assess the interaction between drugs and cystine stones in cystinuric patients.

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Akcaboy, Meltem, e Sevcan A. Bakkaloglu. "Cystinuria in Childhood". Klinische Pädiatrie 233, n.º 04 (julho de 2021): 200–202. http://dx.doi.org/10.1055/a-1497-2269.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Lalic, Tijana, Biljana Beleslin, Jasmina Ciric, Mirjana Stojkovic, Slavica Savic, Tanja Nisic, Milos Stojanovic e Milos Zarkovic. "Recurrent nephrolithiasis: Cystinuria". Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor 21, n.º 61 (2016): 7–20. http://dx.doi.org/10.5937/medgla1661007l.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Boutros, Marylise, Caroline Vicanek, Rima Rozen e Paul Goodyer. "Transient neonatal cystinuria". Kidney International 67, n.º 2 (fevereiro de 2005): 443–48. http://dx.doi.org/10.1111/j.1523-1755.2005.67100.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Anderton, John G. "Cystinuria: An Update". Journal of the Royal Society of Medicine 91, n.º 4 (abril de 1998): 220–21. http://dx.doi.org/10.1177/014107689809100415.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Sumorok, Nicola, e David S. Goldfarb. "Update on cystinuria". Current Opinion in Nephrology and Hypertension 22, n.º 4 (julho de 2013): 427–31. http://dx.doi.org/10.1097/mnh.0b013e3283621c5d.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Rogers, Alexandra, Samer Kalakish, Rahul A. Desai e Dean G. Assimos. "Management of Cystinuria". Urologic Clinics of North America 34, n.º 3 (agosto de 2007): 347–62. http://dx.doi.org/10.1016/j.ucl.2007.04.006.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Joly, Dominique, Philippe Rieu, Arnaud Méjean, Marie-France Gagnadoux, Michel Daudon e P. Jungers. "Treatment of cystinuria". Pediatric Nephrology 13, n.º 9 (24 de novembro de 1999): 945–50. http://dx.doi.org/10.1007/s004670050736.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Jurkiewicz, Beata, e Joanna Samotyjek. "Difficulties in the surgical treatment of patients with cystinuria – a case report". Pediatria i Medycyna Rodzinna 18, n.º 2 (16 de setembro de 2022): 163–68. http://dx.doi.org/10.15557/pimr.2022.0024.

Texto completo da fonte

Resumo:

Cystinuria is an autosomal recessive disorder. Two genes responsible for cystinuria have been identified: SLC3A1 (chromosome 2p21) and SL7A9 (chromosome 19q12). Their mutations cause high clinical variability in the course of the disorder. Over the past 10 years, an increase in the prevalence of cystinuria has been observed, which is now approximately 1:7,000 newborns. Similarly to cystic fibrosis, it is one of the most common diseases with this pattern of inheritance. Its clinical picture usually includes active stone formation (at least twice a year) and short periods of remission. Cystinuria relatively quickly leads to chronic renal failure. Patients with this disorder require constant supervision as well as monitoring of treatment outcomes. This paper presents a case of a 17-year-old boy diagnosed with cystinuria at the age of 3 months, when first bilateral pelvicalyceal stones were found on ultrasound. Immediately after the diagnosis, fluid supply was increased, treatment with captopril and a mixture of citrates (Shohl’s solution) was initiated, which in later years was switched to potassium citrate/tiopronin. The implemented conservative treatment and constant nephrological care failed to prevent relapses in the patient. The boy underwent a total of 40 surgical interventions, including minimally invasive endoscopic procedures (extracorporeal lithotripsy, percutaneous nephrolithotripsy, ureteroscopic lithotripsy, retrograde intrarenal surgery) and three open surgeries to completely remove kidney stones.

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Vyoralová, Zuzana, e Tomáš Šálek. "Recurrent urinary tract infections and cystinuria". Urologie pro praxi 20, n.º 4 (10 de outubro de 2019): 186–90. http://dx.doi.org/10.36290/uro.2019.075.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Mori, Ikuo, Taisei Miyauchi, Haruo Ito, Jun Shimzaki e Shino Murakami. "CLINICAL STUDY ON CYSTINURIA". Japanese Journal of Urology 77, n.º 10 (1986): 1559–65. http://dx.doi.org/10.5980/jpnjurol1928.77.10_1559.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Guillén, Marisa, e Dolores Corella. "Cystinuria subtype and nephrolithiasis". Kidney International 56, n.º 1 (julho de 1999): 353–54. http://dx.doi.org/10.1046/j.1523-1755.1999.00550.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Goldfarb, David S., e Michael Grasso. "Case Studies in Cystinuria". Urologic Nursing 37, n.º 2 (2018): 90. http://dx.doi.org/10.7257/1053-816x.2017.37.2.90.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

NG, CHRISTOPHER S., e STEVAN B. STREEM. "Contemporary Management of Cystinuria". Journal of Endourology 13, n.º 9 (novembro de 1999): 647–51. http://dx.doi.org/10.1089/end.1999.13.647.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Ekberg, M., J. O. Jeppsson e T. Denneberg. "PENICILLAMINE TREATMENT OF CYSTINURIA". Acta Medica Scandinavica 195, n.º 1-6 (24 de abril de 2009): 415–19. http://dx.doi.org/10.1111/j.0954-6820.1974.tb08162.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Tuso, Phil, Michelle Barnett, Chikao Yasunaga e Donald Nortman. "Cystinuria and Renal Transplantation". Nephron 63, n.º 4 (1993): 478. http://dx.doi.org/10.1159/000187262.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Servais, Aude, Kay Thomas, Luca Dello Strologo, John A. Sayer, Soumeya Bekri, Aurelia Bertholet-Thomas, Matthew Bultitude et al. "Cystinuria: clinical practice recommendation". Kidney International 99, n.º 1 (janeiro de 2021): 48–58. http://dx.doi.org/10.1016/j.kint.2020.06.035.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Bai, Yunjin, Yin Tang, Ping Han e Jia Wang. "Gene therapy for cystinuria". Urolithiasis 47, n.º 3 (25 de janeiro de 2019): 309–10. http://dx.doi.org/10.1007/s00240-019-01111-7.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Biyani, Chandra S., e Jon J. Cartledge. "Cystinuria—Diagnosis and Management". EAU-EBU Update Series 4, n.º 5 (outubro de 2006): 175–83. http://dx.doi.org/10.1016/j.eeus.2006.06.001.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Thoma, Clemens. "Cystinuria — supplement supports solubilization". Nature Reviews Urology 14, n.º 6 (21 de fevereiro de 2017): 324. http://dx.doi.org/10.1038/nrurol.2017.27.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Gold, R. J. M., M. J. Dobrinski e D. P. Gold. "Cystinuria and mental deficiency". Clinical Genetics 12, n.º 6 (23 de abril de 2008): 329–32. http://dx.doi.org/10.1111/j.1399-0004.1977.tb00951.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Wright, Ernest M. "Cystinuria defect expresses itself". Nature Genetics 6, n.º 4 (abril de 1994): 328–29. http://dx.doi.org/10.1038/ng0494-328.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Kurczynski, Thaddeus W. "NEUROLOGICAL COMPLICATIONS OF CYSTINURIA". Developmental Medicine & Child Neurology 21, n.º 6 (12 de novembro de 2008): 811–12. http://dx.doi.org/10.1111/j.1469-8749.1979.tb01707.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

DENNIS, JENNIFER, e DAVID C. TAYLOR. "Neurological Complications of Cystinuria". Developmental Medicine & Child Neurology 22, n.º 3 (12 de novembro de 2008): 402–3. http://dx.doi.org/10.1111/j.1469-8749.1980.tb03725.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Thomas, Kay, Kathie Wong, John Withington, Matthew Bultitude e Angela Doherty. "Cystinuria—a urologist's perspective". Nature Reviews Urology 11, n.º 5 (25 de março de 2014): 270–77. http://dx.doi.org/10.1038/nrurol.2014.51.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Clayton-Smith, Jill. "Jeune syndrome and cystinuria". American Journal of Medical Genetics 41, n.º 4 (15 de dezembro de 1991): 531. http://dx.doi.org/10.1002/ajmg.1320410431.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Claes, Donna J., e Elizabeth Jackson. "Cystinuria: mechanisms and management". Pediatric Nephrology 27, n.º 11 (27 de janeiro de 2012): 2031–38. http://dx.doi.org/10.1007/s00467-011-2092-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Lee, Franklin, Ruthie Su e Thomas Lendvay. "Cystinuria Crystals: An Image From a 14-Year-Old Girl With Cystinuria". Urology 81, n.º 4 (abril de 2013): e29. http://dx.doi.org/10.1016/j.urology.2012.12.014.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

GUCEV, ZORAN, NADICA RISTOSKA-BOJKOVSKA, KATERINA POPOVSKA-JANKOVIC, EMILIJA SUKAROVA-STEFANOVSKA, VELIBOR TASIC, DIJANA PLASESKA-KARANFILSKA e GEORGI D. EFREMOV. "Cystinuria AA (B): digenic inheritance with three mutations in two cystinuria genes". Journal of Genetics 90, n.º 1 (abril de 2011): 157–59. http://dx.doi.org/10.1007/s12041-011-0045-2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Bultitude, M., e K. Thomas. "‘Cystinuria Support’ – a new dedicated forum for patients with the rare disease cystinuria". European Urology Open Science 19 (julho de 2020): e717. http://dx.doi.org/10.1016/s2666-1683(20)33058-5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Gillion, Valentine, Thibaud-Pierre Saussez, Sandy Van Nieuwenhove e Michel Jadoul. "Extremely rapid stone formation in cystinuria: look out for dietary supplements!" Clinical Kidney Journal 14, n.º 6 (28 de janeiro de 2021): 1694–96. http://dx.doi.org/10.1093/ckj/sfab013.

Texto completo da fonte

Resumo:

Abstract Cystinuria is an autosomal recessive disease characterized by recurrent nephrolithiasis. The prevention of new stones is based on diluting and alkalinizing urine, as well as a low salt and moderate protein intake. The avoidance of food rich in methionine (the precursor of cystine) is also advocated. We report the case of a young adult adherent to the preventative strategy who was stone-free and within months formed a large stone. This coincided with the recent intake of a dietary supplement containing both cystine and methionine. Patients and physicians should be aware of the potential harm of such supplements in patients with cystinuria.

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Singh, Prabhakar, Richa Gupta e Abhishek Gupta. "Cystinuria in association with cataract". Indian Journal of Ophthalmology 68, n.º 1 (2020): 209. http://dx.doi.org/10.4103/ijo.ijo_1330_19.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Ala-Opas, Martti, Ilkka Sipilä, Seppo Kivinen e Timo Lehtonen. "Diagnostic Problems Associated with Cystinuria". Scandinavian Journal of Urology and Nephrology 24, n.º 2 (janeiro de 1990): 133–35. http://dx.doi.org/10.3109/00365599009180378.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

KAYNAR, Kübra, Onur KÜÇÜK e Canan ŞEHİT. "Unusual Cause of Nephrolithiasis: Cystinuria". Turkiye Klinikleri Journal of Case Reports 27, n.º 1 (2019): 50–53. http://dx.doi.org/10.5336/caserep.2018-61835.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!